A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

Orchard Therapeutics has tasked Robin Kenselaar with accelerating growth of Lenmeldy, the world’s most expensive drug, ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Mayor Jerry Treñas of this city has denied any involvement in the illegal drug trade, adding his name has never been included ...

One of the most significant challenges in cancer treatment is the development of drug resistance by cancer cells, which often ...

In a significant move towards improving patient safety and optimising drug usage, the Bhopal Memorial Hospital and Research Centre (BMHRC) on Tuesday announced that it has introduced a new Essential ...

If Fierce Pharma Marketing’s annual list of the top 10 biggest potential drug launches of the coming year is any indication, ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.